npc 12626 has been researched along with ibogaine in 1 studies
Studies (npc 12626) | Trials (npc 12626) | Recent Studies (post-2010) (npc 12626) | Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) |
---|---|---|---|---|---|
55 | 0 | 0 | 445 | 8 | 136 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brave, S; French, D; Geter-Douglass, B; Witkin, JM | 1 |
1 other study(ies) available for npc 12626 and ibogaine
Article | Year |
---|---|
Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.
Topics: Amino Acids; Animals; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Ibogaine; Male; Mice; Piperidines; Pyrrolidinones; Receptors, N-Methyl-D-Aspartate; Strychnine | 1995 |